Knockdown of TRPM8 Suppresses Cancer Malignancy and Enhances Epirubicin-induced Apoptosis in Human Osteosarcoma Cells

@article{Wang2013KnockdownOT,
  title={Knockdown of TRPM8 Suppresses Cancer Malignancy and Enhances Epirubicin-induced Apoptosis in Human Osteosarcoma Cells},
  author={Y. Wang and Z. Yang and Z. Meng and H. Cao and G. Zhu and T. Liu and X. Wang},
  journal={International Journal of Biological Sciences},
  year={2013},
  volume={10},
  pages={90 - 102}
}
  • Y. Wang, Z. Yang, +4 authors X. Wang
  • Published 2013
  • Biology, Medicine
  • International Journal of Biological Sciences
  • As the function of transient receptor potential melastatin member 8 (TRPM8) in osteosarcoma is still unknown, we aim to investigate the possible effects and potential mechanisms of TRPM8 on cell proliferation, metastasis and chemosensitivity in osteosarcoma cells. We find that TRPM8 is aberrantly over-expressed in human osteosarcoma tissues and cell lines. Knockdown of TRPM8 by siRNA in osteosarcoma cells leads to the impaired regulation of intracellular Ca2+ concentration and then the Akt-GSK… CONTINUE READING
    Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway
    • 34
    • PDF
    TRPM8 is required for survival and radioresistance of glioblastoma cells
    • 14
    • PDF
    Transient Receptor Potential Cation Channels in Cancer Therapy
    • 3
    • PDF
    High expression of TRPM8 predicts poor prognosis in patients with osteosarcoma
    • 11
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 50 REFERENCES
    Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells.
    • 59
    • PDF
    Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.
    • 109
    TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?
    • 118
    • PDF
    Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells
    • 116
    • PDF
    NF-?B as a therapeutic target in cancer
    • 464
    NF-kappaB as a therapeutic target in cancer.
    • 124
    The p38 MAPK–MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment
    • 39
    • PDF